From the Food and Drug Administration.
Henney
J E
JE
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001688:Biological Products / Q000600:supply & distribution*; D020680:Bronchoscopes / Q000382:microbiology*; D003428:Cross Infection / Q000209:etiology / Q000517:prevention & control; D004203:Disinfection; D017277:Drug Approval; D019723:Endoscopes / Q000382:microbiology; D004866:Equipment Contamination; D006801:Humans; D016756:Immunoglobulins, Intravenous; D014481:United States; D014486:United States Food and Drug Administration; D020713:Vancomycin Resistance; D014769:Virginiamycin / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D001688:Biological Products; D016756:Immunoglobulins, Intravenous; D014769:Virginiamycin; C062940:quinupristin-dalfopristin